Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease

  1. Elodie Luche
  2. Virginie Robert
  3. Vincent Cuminetti
  4. Céline Pomié
  5. Quentin Sastourné-Array
  6. Aurélie Waget
  7. Emmanuelle Arnaud
  8. Audrey Varin
  9. Elodie Labit
  10. Patrick Laharrague
  11. Remy Burcelin
  12. Louis Casteilla
  13. Beatrice Cousin  Is a corresponding author
  1. Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, France
  2. INSERM U1048, France
  3. Université de Toulouse, EFS, INP-ENVT, Inserm U1031, UPS; BP 84225, France
  4. U1048 , France
  5. STROMALab, France

Abstract

Activation and increased numbers of inflammatory macrophages, in adipose tissue (AT) are deleterious in metabolic diseases. Up to now, AT macrophages (ATM) accumulation was considered to be due to blood infiltration or local proliferation, although the presence of resident hematopoietic stem/progenitor cells (Lin-/Sca+/c-Kit+; LSK phenotype) in the AT (AT-LSK) has been reported. By using transplantation of sorted AT-LSK and gain and loss of function studies we show that some of the inflammatory ATM inducing metabolic disease, originate from resident AT-LSK. Transplantation of AT-LSK sorted from high fat diet-fed (HFD) mice is sufficient to induce ATM accumulation, and to transfer metabolic disease in control mice. Conversely, the transplantation of control AT-LSK improves both AT-inflammation and glucose homeostasis in HFD mice. Our results clearly demonstrate that resident AT-LSK are one of the key point of metabolic disease, and could thus constitute a new promising therapeutic target to fight against metabolic disease.

Article and author information

Author details

  1. Elodie Luche

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Virginie Robert

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Vincent Cuminetti

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Céline Pomié

    INSERM U1048, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Quentin Sastourné-Array

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Aurélie Waget

    INSERM U1048, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Emmanuelle Arnaud

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Audrey Varin

    STROMALab, Université de Toulouse, EFS, INP-ENVT, Inserm U1031, UPS; BP 84225, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Elodie Labit

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Patrick Laharrague

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Remy Burcelin

    U1048 , Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Louis Casteilla

    STROMALab, Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, UPS, Toulouse, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Beatrice Cousin

    Université de Toulouse, CNRS ERL 5311, EFS, INP-ENVT, Inserm U1031, STROMALab, Toulouse, France
    For correspondence
    beatrice.cousin@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2952-4601

Funding

Aviesan/AstraZeneca

  • Louis Casteilla
  • Beatrice Cousin

Société Francophone du Diabète

  • Beatrice Cousin

ANR (ANR 16-CE14-0006-01)

  • Beatrice Cousin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animals were maintained in accordance to guidelines of the European Community Council. All experimental procedures were done in compliance with European regulations for animal experimentation. The authors have received requested approval from their Institutional Ethic Committee, and from Ministry of National Education, Higher Education and Research (# 2691-2015110616015905) for all the experiments performed.

Copyright

© 2017, Luche et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,077
    views
  • 207
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Elodie Luche
  2. Virginie Robert
  3. Vincent Cuminetti
  4. Céline Pomié
  5. Quentin Sastourné-Array
  6. Aurélie Waget
  7. Emmanuelle Arnaud
  8. Audrey Varin
  9. Elodie Labit
  10. Patrick Laharrague
  11. Remy Burcelin
  12. Louis Casteilla
  13. Beatrice Cousin
(2017)
Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease
eLife 6:e23194.
https://doi.org/10.7554/eLife.23194

Share this article

https://doi.org/10.7554/eLife.23194

Further reading

    1. Developmental Biology
    2. Neuroscience
    Taro Ichimura, Taishi Kakizuka ... Takeharu Nagai
    Tools and Resources

    We established a volumetric trans-scale imaging system with an ultra-large field-of-view (FOV) that enables simultaneous observation of millions of cellular dynamics in centimeter-wide three-dimensional (3D) tissues and embryos. Using a custom-made giant lens system with a magnification of ×2 and a numerical aperture (NA) of 0.25, and a CMOS camera with more than 100 megapixels, we built a trans-scale scope AMATERAS-2, and realized fluorescence imaging with a transverse spatial resolution of approximately 1.1 µm across an FOV of approximately 1.5×1.0 cm2. The 3D resolving capability was realized through a combination of optical and computational sectioning techniques tailored for our low-power imaging system. We applied the imaging technique to 1.2 cm-wide section of mouse brain, and successfully observed various regions of the brain with sub-cellular resolution in a single FOV. We also performed time-lapse imaging of a 1-cm-wide vascular network during quail embryo development for over 24 hr, visualizing the movement of over 4.0×105 vascular endothelial cells and quantitatively analyzing their dynamics. Our results demonstrate the potential of this technique in accelerating production of comprehensive reference maps of all cells in organisms and tissues, which contributes to understanding developmental processes, brain functions, and pathogenesis of disease, as well as high-throughput quality check of tissues used for transplantation medicine.

    1. Developmental Biology
    2. Genetics and Genomics
    Mehul Vora, Jonathan Dietz ... Cathy Savage-Dunn
    Research Article

    Smads and their transcription factor partners mediate the transcriptional responses of target cells to secreted ligands of the transforming growth factor-β (TGF-β) family, including those of the conserved bone morphogenetic protein (BMP) family, yet only a small number of direct target genes have been well characterized. In C. elegans, the BMP2/4 ortholog DBL-1 regulates multiple biological functions, including body size, via a canonical receptor-Smad signaling cascade. Here, we identify functional binding sites for SMA-3/Smad and its transcriptional partner SMA-9/Schnurri based on ChIP-seq peaks (identified by modEncode) and expression differences of nearby genes identified from RNA-seq analysis of corresponding mutants. We found that SMA-3 and SMA-9 have both overlapping and unique target genes. At a genome-wide scale, SMA-3/Smad acts as a transcriptional activator, whereas SMA-9/Schnurri direct targets include both activated and repressed genes. Mutations in sma-9 partially suppress the small body size phenotype of sma-3, suggesting some level of antagonism between these factors and challenging the prevailing model for Schnurri function. Functional analysis of target genes revealed a novel role in body size for genes involved in one-carbon metabolism and in the endoplasmic reticulum (ER) secretory pathway, including the disulfide reductase dpy-11. Our findings indicate that Smads and SMA-9/Schnurri have previously unappreciated complex genetic and genomic regulatory interactions that in turn regulate the secretion of extracellular components like collagen into the cuticle to mediate body size regulation.